Edesa Biotech (EDSA) EBT Margin (2013 - 2020)
Edesa Biotech (EDSA) posted EBT Margin of 402899.6% for Q3 2020, down 24995.62% sequentially from 1605.46% in Q2 2020.
Edesa Biotech (EDSA) EBT Margin (2013 - 2020) Analysis & Trends
Edesa Biotech has reported EBT Margin for 8 years, with the latest figure at 402899.6% in Q3 2020.
- Quarterly EBT Margin changed N/A year-over-year to 402899.6% in Q3 2020, while the trailing twelve-month figure through Jun 2021 was 2334161.4% (down 233244518.0% YoY) and the FY2020 annual result came in at 1935.34%, down 125953.0% from the prior year.
- EBT Margin retreated to 402899.6% in Q3 2020 per EDSA's latest filing, from 1605.46% in the prior quarter.
- Over five years, EBT Margin peaked at 696.06% in Q3 2017 and troughed at 402899.6% in Q3 2020.
- A 5-year average of 48835.06% and a median of 1476.67% in 2020 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2017 and 2020: EBT Margin sank 578659 bps in 2017, then jumped 25719594 bps in 2020.
- Over 5 years, EBT Margin stood at 1046.75% in 2016, then plunged by 553 bps to 6833.34% in 2017, then surged by 69 bps to 2111.61% in 2018, then jumped by 52 bps to 1014.41% in 2019, then plunged by 39618 bps to 402899.6% in 2020.
- According to Business Quant data, EBT Margin over the past three periods registered 402899.6%, 1605.46%, and 1347.89% for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Edesa Biotech | 43.15 Mn | 43.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -402,899.60% |
| Jun 30, 2020 | -1,605.46% |
| Mar 31, 2020 | -1,347.89% |
| Dec 31, 2019 | -1,014.41% |
| Jun 30, 2019 | -258,801.40% |
| Mar 31, 2018 | -2,111.61% |
| Dec 31, 2017 | -6,833.34% |
| Sep 30, 2017 | 696.06% |
| Jun 30, 2017 | -5,943.70% |
| Mar 31, 2017 | -1,751.34% |
| Dec 31, 2016 | -1,046.75% |
| Sep 30, 2016 | -108.19% |
| Jun 30, 2016 | -659.38% |
| Mar 31, 2016 | -263.84% |
| Dec 31, 2015 | -355.71% |
| Sep 30, 2015 | 717.43% |
| Jun 30, 2015 | 299.84% |
| Mar 31, 2015 | -292.49% |
| Dec 31, 2014 | -627.14% |
| Dec 31, 2013 | -34,668.26% |